The rising interest in GLP-1 agonists for diabetes has generated a debate about application forms : transdermal systems versus tablets . Traditionally , GLP-1 therapies were solely available in pill form, https://blakegwxy949593.vblogetin.com/47044328/glp-1-transdermal-delivery-systems-vs-pills-which-right-for-individuals